ATXS - Astria Therapeutics, Inc.

QQQ $ 480.29 $ -1.01 (-0.21 %)

DIA $ 408.54 $ -0.35 (-0.09 %)

SPY $ 558.65 $ -0.51 (-0.09 %)

TLT $ 98.68 $ 0.38 (0.39 %)

GLD $ 232.46 $ -1.26 (-0.54 %)

Previous Close

$ 11.68

Open

$ 11.64

Bid

$ 11.84 x 200

Ask

$ 11.87 x 100

Day's Range

$ 11.46 - $ 12.03

52 Week Range

$ 4.26 - $ 16.90

Volume

270,268

Average Volume

Market Cap

326.39M

Beta (5Y Monthly)

$ 1.24

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	03-04-2024	12-31-2023	10-K
4	11-13-2023	09-30-2023	10-Q
5	08-07-2023	06-30-2023	10-Q
6	05-11-2023	03-31-2023	10-Q
7	03-22-2023	12-31-2022	10-K
8	11-10-2022	09-30-2022	10-Q
9	08-09-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-10-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-09-2021	06-30-2021	10-Q
14	05-13-2021	03-31-2021	10-Q
15	03-11-2021	12-31-2020	10-K
16	11-12-2020	09-30-2020	10-Q
17	08-10-2020	06-30-2020	10-Q
18	05-12-2020	03-31-2020	10-Q
19	03-10-2020	12-31-2019	10-K
20	11-07-2019	09-30-2019	10-Q
21	08-08-2019	06-30-2019	10-Q
22	05-14-2019	03-31-2019	10-Q
23	03-14-2019	12-31-2018	10-K
24	11-13-2018	09-30-2018	10-Q
25	08-09-2018	06-30-2018	10-Q
26	05-10-2018	03-31-2018	10-Q
27	03-15-2018	12-31-2017	10-K
28	11-09-2017	09-30-2017	10-Q
29	08-10-2017	06-30-2017	10-Q
30	05-11-2017	03-31-2017	10-Q
31	03-16-2017	12-31-2016	10-K
32	11-10-2016	09-30-2016	10-Q
33	08-11-2016	06-30-2016	10-Q
34	05-12-2016	03-31-2016	10-Q
35	03-15-2016	12-31-2015	10-K
36	11-12-2015	09-30-2015	10-Q
37	08-13-2015	06-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Wedbush Reiterates Outperform on Astria Th...
08/13/2024 12:37:44

Wedbush analyst Laura Chico reiterates Astria Therapeutics (NASDAQ:ATXS) with a Outperform and maintains $22 price target.

Oppenheimer Maintains Outperform on Astria...
08/13/2024 12:19:05

Oppenheimer analyst Hartaj Singh maintains Astria Therapeutics (NASDAQ:ATXS) with a Outperform and raises the price target f...

HC Wainwright & Co. Reiterates Buy on Astr...
08/13/2024 11:07:40

HC Wainwright & Co. analyst Joseph Pantginis reiterates Astria Therapeutics (NASDAQ:ATXS) with a Buy and maintains $16 p...

Astria Therapeutics Q2 2024 Adj EPS $(0.43...
08/12/2024 20:26:33

Astria Therapeutics (NASDAQ:ATXS) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of...

TD Cowen Initiates Coverage On Astria Ther...
07/29/2024 10:59:58

TD Cowen analyst Stacy Ku initiates coverage on Astria Therapeutics (NASDAQ:ATXS) with a Buy rating and announces Price Targ...

Oppenheimer Maintains Outperform on Astria...
05/21/2024 12:02:23

Oppenheimer analyst Hartaj Singh maintains Astria Therapeutics (NASDAQ:ATXS) with a Outperform and lowers the price target f...

HC Wainwright & Co. Reiterates Buy on Astr...
05/10/2024 19:00:27

HC Wainwright & Co. analyst Joseph Pantginis reiterates Astria Therapeutics (NASDAQ:ATXS) with a Buy and maintains $16 p...

Wedbush Reiterates Outperform on Astria Th...
05/10/2024 13:36:41

Wedbush analyst Laura Chico reiterates Astria Therapeutics (NASDAQ:ATXS) with a Outperform and maintains $22 price target.

Astria Therapeutics Q1 2024 GAAP EPS $(0.3...
05/09/2024 21:36:24

Astria Therapeutics (NASDAQ:ATXS) reported quarterly losses of $(0.38) per share which met the analyst consensus estimate.

HC Wainwright & Co. Maintains Buy on Astri...
04/23/2024 10:22:29

HC Wainwright & Co. analyst Joseph Pantginis maintains Astria Therapeutics (NASDAQ:ATXS) with a Buy and lowers the price...

Wedbush Maintains Outperform on Astria The...
03/26/2024 13:34:23

Wedbush analyst Laura Chico maintains Astria Therapeutics (NASDAQ:ATXS) with a Outperform and raises the price target from $...

HC Wainwright & Co. Maintains Buy on Astri...
03/25/2024 16:35:33

HC Wainwright & Co. analyst Joseph Pantginis maintains Astria Therapeutics (NASDAQ:ATXS) with a Buy and maintains $18 pr...

Astria Therapeutics shares are trading hig...
03/25/2024 12:43:42

Astria Therapeutics Announces Initial Proo...
03/25/2024 11:40:03

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic...

why-lifecore-biomedical-shares-are-trading-lower-by-around-32-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Lifecore Biomedical Shares Are Trading...
03/20/2024 18:03:46

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it con...

HC Wainwright & Co. Reiterates Buy on Astr...
03/14/2024 11:13:16

HC Wainwright & Co. analyst Joseph Pantginis reiterates Astria Therapeutics (NASDAQ:ATXS) with a Buy and maintains $18 p...

Wedbush Reiterates Outperform on Astria Th...
03/05/2024 13:34:27

Wedbush analyst Laura Chico reiterates Astria Therapeutics (NASDAQ:ATXS) with a Outperform and maintains $17 price target.

HC Wainwright & Co. Reiterates Buy on Astr...
03/05/2024 12:04:35

HC Wainwright & Co. analyst Joseph Pantginis reiterates Astria Therapeutics (NASDAQ:ATXS) with a Buy and maintains $18 p...

Astria Therapeutics Q4 EPS $(0.86) Down Fr...
03/04/2024 21:20:25

Astria Therapeutics (NASDAQ:ATXS) reported quarterly losses of $(0.86) per share. This is a 19.44 percent decrease over losses ...

Wedbush Reiterates Outperform on Astria Th...
01/30/2024 16:02:17

Wedbush analyst Laura Chico reiterates Astria Therapeutics (NASDAQ:ATXS) with a Outperform and maintains $17 price target.